Psychiatrists said the problem for some patients has been compounded by a nationwide shortage of Adderall in recent months due to manufacturing delays at Teva Pharmaceutical Industries Ltd (TEVA.TA), the Israel-based company that produces it. Teva said that, in addition to the production issues, there had been a "significant rise" in national prescription rates for the drug.